BioLineRx (BLRX) Current Leases (2019 - 2025)

BioLineRx's Current Leases history runs 7 years deep, the most recent figure standing at $977000.0 for Q4 2025.

• In Q4 2025, Current Leases fell 9.62% year-over-year to $977000.0; the TTM figure through Dec 2025 stood at $977000.0 (down 9.62% YoY), while the FY2025 annual figure was $977000.0, down 9.62% from the prior year.
• Current Leases was $977000.0 for Q4 2025 at BioLineRx, down from $1.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.7 million in Q4 2022 to a low of $977000.0 in Q4 2025.
• Historically, Current Leases has averaged $1.4 million across 5 years, with a median of $1.4 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Leases grew 9.44% in 2023, then decreased 27.79% in 2024.
• A 5-year view of Current Leases shows it stood at $1.7 million in 2021, then grew by 0.17% to $1.7 million in 2022, then declined by 25.39% to $1.3 million in 2023, then decreased by 16.2% to $1.1 million in 2024, then slipped by 9.62% to $977000.0 in 2025.
• The last three Current Leases figures came in at $977000.0 (Q4 2025), $1.0 million (Q3 2025), and $998000.0 (Q2 2025), per Business Quant data.